Combination Approaches and Subtypes of Melanoma

This chapter explores the use of BRF and MEK inhibitors for metastatic melanoma, emphasizing the approved combinations and common side effect of pyrexia. It also discusses rare subtypes of melanoma, such as UVL, mucosal, and acral melanomas.